oprd_human
NAME
4RWD
ORGANISM
Human (Homo sapiens)
PROTEIN NAME
oprd_human
SOURCE
SWISSPROT
SEQUENCE
Perspective:
Wild-type
Construct
|
|
|
|
|
|
|
|
|
|
N-term | |||||||||
M
|
E
|
P
|
A
|
P
|
S
|
A
|
G
|
A
|
E
|
10 |
|
|
|
|
|
|
|
|
|
|
L
|
Q
|
P
|
P
|
L
|
F
|
A
|
N
|
A
|
S
|
20 |
|
|
|
|
|
|
|
|
|
|
D
|
A
|
Y
|
P
|
S
|
A
|
C
|
P
|
S
|
A
|
30 |
|
|
|
|
|
|
|
|
||
G
|
A
|
N
|
A
|
S
|
G
|
P
|
P
|
G
|
A
|
40 |
TM1 | |||||||||
R
|
S
|
A
|
S
|
S
|
L
|
A
|
L
|
A
|
I
|
50 |
A
|
I
|
T
|
A
|
L
|
Y
|
S
|
A
|
V
|
C
|
60 |
A
|
V
|
G
|
L
|
L
|
G
|
N
|
V
|
L
|
V
|
70 |
M
|
F
|
G
|
I
|
V
|
R
|
Y
|
T
|
K
|
M
|
80 |
ICL1 | TM2 | ||||||||
K
|
T
|
A
|
T
|
N
|
I
|
Y
|
I
|
F
|
N
|
90 |
L
|
A
|
L
|
A
|
D
|
A
|
L
|
A
|
T
|
S
|
100 |
T
|
L
|
P
|
F
|
Q
|
S
|
A
|
K
|
Y
|
L
|
110 |
ECL1 | TM3 | ||||||||
M
|
E
|
T
|
W
|
P
|
F
|
G
|
E
|
L
|
L
|
120 |
C
|
K
|
A
|
V
|
L
|
S
|
I
|
D
|
Y
|
Y
|
130 |
N
|
M
|
F
|
T
|
S
|
I
|
F
|
T
|
L
|
T
|
140 |
M
|
M
|
S
|
V
|
D
|
R
|
Y
|
I
|
A
|
V
|
150 |
ICL2 | |||||||||
C
|
H
|
P
|
V
|
K
|
A
|
L
|
D
|
F
|
R
|
160 |
TM4 | |||||||||
T
|
P
|
A
|
K
|
A
|
K
|
L
|
I
|
N
|
I
|
170 |
C
|
I
|
W
|
V
|
L
|
A
|
S
|
G
|
V
|
G
|
180 |
V
|
P
|
I
|
M
|
V
|
M
|
A
|
V
|
T
|
R
|
190 |
ECL2 | |||||||||
P
|
R
|
D
|
G
|
A
|
V
|
V
|
C
|
M
|
L
|
200 |
TM5 | |||||||||
Q
|
F
|
P
|
S
|
P
|
S
|
W
|
Y
|
W
|
D
|
210 |
T
|
V
|
T
|
K
|
I
|
C
|
V
|
F
|
L
|
F
|
220 |
A
|
F
|
V
|
V
|
P
|
I
|
L
|
I
|
I
|
T
|
230 |
V
|
C
|
Y
|
G
|
L
|
M
|
L
|
L
|
R
|
L
|
240 |
ICL3 | |||||||||
R
|
S
|
V
|
R
|
L
|
L
|
S
|
G
|
S
|
K
|
250 |
TM6 | |||||||||
E
|
K
|
D
|
R
|
S
|
L
|
R
|
R
|
I
|
T
|
260 |
R
|
M
|
V
|
L
|
V
|
V
|
V
|
G
|
A
|
F
|
270 |
V
|
V
|
C
|
W
|
A
|
P
|
I
|
H
|
I
|
F
|
280 |
V
|
I
|
V
|
W
|
T
|
L
|
V
|
D
|
I
|
D
|
290 |
ECL3 | TM7 | ||||||||
R
|
R
|
D
|
P
|
L
|
V
|
V
|
A
|
A
|
L
|
300 |
H
|
L
|
C
|
I
|
A
|
L
|
G
|
Y
|
A
|
N
|
310 |
S
|
S
|
L
|
N
|
P
|
V
|
L
|
Y
|
A
|
F
|
320 |
H8 | |||||||||
L
|
D
|
E
|
N
|
F
|
K
|
R
|
C
|
F
|
R
|
330 |
|
|
||||||||
Q
|
L
|
C
|
R
|
K
|
P
|
C
|
G
|
R
|
P
|
340 |
|
|
|
|
|
|
|
|
|
|
C-term | |||||||||
D
|
P
|
S
|
S
|
F
|
S
|
R
|
A
|
R
|
E
|
350 |
|
|
|
|
|
|
|
|
|
|
A
|
T
|
A
|
R
|
E
|
R
|
V
|
T
|
A
|
C
|
360 |
|
|
|
|
|
|
|
|
|
|
T
|
P
|
S
|
D
|
G
|
P
|
G
|
G
|
G
|
A
|
370 |
|
|
A
|
A
|
|
|
|
|
|
|
|
|
|
|
|
hemagglutin | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FLAG | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
His(10) | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TEV proteas | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BRIL (b562R | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
TM1 | |||||||||
|
G
|
A
|
R
|
S
|
A
|
S
|
S
|
L
|
A
|
47 |
L
|
A
|
I
|
A
|
I
|
T
|
A
|
L
|
Y
|
S
|
57 |
A
|
V
|
C
|
A
|
V
|
G
|
L
|
L
|
G
|
N
|
67 |
V
|
L
|
V
|
M
|
F
|
G
|
I
|
V
|
R
|
Y
|
77 |
ICL1 | TM2 | ||||||||
T
|
K
|
M
|
K
|
T
|
A
|
T
|
N
|
I
|
Y
|
87 |
I
|
F
|
N
|
L
|
A
|
L
|
A
|
D
|
A
|
L
|
97 |
A
|
T
|
S
|
T
|
L
|
P
|
F
|
Q
|
S
|
A
|
107 |
ECL1 | |||||||||
K
|
Y
|
L
|
M
|
E
|
T
|
W
|
P
|
F
|
G
|
117 |
TM3 | |||||||||
E
|
L
|
L
|
C
|
K
|
A
|
V
|
L
|
S
|
I
|
127 |
D
|
Y
|
Y
|
N
|
M
|
F
|
T
|
S
|
I
|
F
|
137 |
T
|
L
|
T
|
M
|
M
|
S
|
V
|
D
|
R
|
Y
|
147 |
ICL2 | |||||||||
I
|
A
|
V
|
C
|
H
|
P
|
V
|
K
|
A
|
L
|
157 |
TM4 | |||||||||
D
|
F
|
R
|
T
|
P
|
A
|
K
|
A
|
K
|
L
|
167 |
I
|
N
|
I
|
C
|
I
|
W
|
V
|
L
|
A
|
S
|
177 |
G
|
V
|
G
|
V
|
P
|
I
|
M
|
V
|
M
|
A
|
187 |
ECL2 | |||||||||
V
|
T
|
R
|
P
|
R
|
D
|
G
|
A
|
V
|
V
|
197 |
TM5 | |||||||||
C
|
M
|
L
|
Q
|
F
|
P
|
S
|
P
|
S
|
W
|
207 |
Y
|
W
|
D
|
T
|
V
|
T
|
K
|
I
|
C
|
V
|
217 |
F
|
L
|
F
|
A
|
F
|
V
|
V
|
P
|
I
|
L
|
227 |
I
|
I
|
T
|
V
|
C
|
Y
|
G
|
L
|
M
|
L
|
237 |
ICL3 | |||||||||
L
|
R
|
L
|
R
|
S
|
V
|
R
|
L
|
L
|
S
|
247 |
TM6 | |||||||||
G
|
S
|
K
|
E
|
K
|
D
|
R
|
S
|
L
|
R
|
257 |
R
|
I
|
T
|
R
|
M
|
V
|
L
|
V
|
V
|
V
|
267 |
G
|
A
|
F
|
V
|
V
|
C
|
W
|
A
|
P
|
I
|
277 |
H
|
I
|
F
|
V
|
I
|
V
|
W
|
T
|
L
|
V
|
287 |
ECL3 | TM7 | ||||||||
D
|
I
|
D
|
R
|
R
|
D
|
P
|
L
|
V
|
V
|
297 |
A
|
A
|
L
|
H
|
L
|
C
|
I
|
A
|
L
|
G
|
307 |
Y
|
A
|
N
|
S
|
S
|
L
|
N
|
P
|
V
|
L
|
317 |
H8 | |||||||||
Y
|
A
|
F
|
L
|
D
|
E
|
N
|
F
|
K
|
R
|
327 |
C
|
F
|
R
|
Q
|
L
|
C
|
R
|
K
|
P
|
C
|
337 |
|
|||||
C-term | |||||
G
|
|
||||
SCHEMATIC
Perspective:
Wild-type
Construct
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DIAGRAMS
MUTATIONS
Position | Wild-type | Mutated |
---|
DELETIONS
MODIFICATIONS
AUXILIARY PROTEINS
Protein_type: signal
Name: hemagglutinin
Sequence: None
Deletions:
Positions: N-term_0 None:None
Presence in Crystal:NO
Remarks: None
Protein_type: tag
Name: FLAG
Sequence: None
Deletions:
Positions: N-term_1 None:None
Presence in Crystal:NO
Remarks: None
Protein_type: tag
Name: His(10)
Sequence: None
Deletions:
Positions: N-term_2 None:None
Presence in Crystal:NO
Remarks: None
Protein_type: prot_cleavage
Name: TEV protease
Sequence: None
Deletions:
Positions: N-term_3 None:None
Presence in Crystal:NO
Remarks: None
Protein_type: fusion
Name: BRIL (b562RIL)
Sequence: None
Deletions:
Positions: N-term_4 None:None
Presence in Crystal:YES
Remarks: None
EXPRESSION
Expression method | Host cell type | Host cell | Remarks |
---|---|---|---|
Baculovirus | Sf9 | Insect | pFastBac1 and Bac-to-bac |
SOLUBILIZATION
Solvent type | Item | Concentration |
---|---|---|
detergent | DDM | 0.75 %w/v |
additive | CHS | 0.15 %w/v |
Remarks:
PURIFICATION
Purification type | Description |
---|---|
Alkylation by Iodoacetamide | None |
Proteolysis by TEV protease | None |
Remarks:None
CRYSTALLIZATION
METHOD: in meso/LCP
TYPE: lipidic cubic phase (LCP) (monoolein (9.9 MAG))
PROTEIN CONCENTRATION: 40 mg/ml
Temperature: 20°C
ph : 6.0-6.0
Remarks: XFEL:After crystals had formed, excess precipitant solution was carefully removed, and this was followed by the addition of ~3 μL of 7.9 MAG to absorb the residual precipitant solution.
Chemical lists
Type | Item | Concentration |
---|---|---|
Additional | ||
unknown | MES pH 6.0 | 0.1 M |
unknown | PEG 400 | 30-32 % v/v |
unknown | Lithium Citrate | 50-180 mM |
Detergent | ||
detergent | DDM | 0.03 % w/v |
Lipid | ||
lipid | CHS | 0.006 %w/v |